Osteoporosis after menopause is a growing
public health concern that impacts bone health.
It is characterised by weak and fracture prone
bones. Women are nearly four times likely as
men to be affected. The goal is to improve a
proper prosthodontic therapy so that residual
ridge resorption is reduced. The main concern
are alveolar bone resorption and tooth loss or
movement, to which osteoporotic women are three
times more sensitive than those without condition.
The goal of prosthodontic treatment should be to
enhance prognosis by modifying the treatment
plan to lower the strain on the alveolar ridge and
thereby reduce progressive resorption.
This article provides an overview of prosthodontic
considerations related to osteoporosis in
postmenopausal women. over the other modalities
of treatment once more.
Key words: osteoporosis, postmenopausal, implant, bone mineral density
Every year, there is evidence that the number of
geriatric patients are increased. Osteoporosis
is a metabolic illness characterised by a loss of
bone mass and a reduction in the microarchitecture of bone tissues, resulting in increased bone
fragility and fracture risk. WHO defined, Bone
Mineral Density less than 2.5 standard deviation below that of a young adult BMD2. In half of
postmenopausal women, osteoporotic fractures
occur. In United States and Europe, about 30%
of postmenopausal women have osteoporosis,
however in India, the prevalence varies between
25% and 62%. The global ageing of populations
has resulted in a significant increase in the incidence of osteoporosis3
A systematic literature search was carried out in
a database in PubMed/Medline, Google Scholar and was completed in October 2020. ‘Osteoporosis’, ‘menopausal osteoporosis’, ‘osteoporotic
prosthodontic treatment’, ‘bone mineral density’,
and ‘dental implant’ were among the key phrases.
The title and abstracts of the research were used
to determine which ones were eligible. For papers
that were found to be inclusive after a review of
abstracts, the whole text was utilised. This was
followed by a manual search (checking references
of relevant review articles and eligible studies for
additional data). Any article that had not been
published in English was disqualified.
Pathophysiology and Risk Factors
Ovarian function declines during menopause,
resulting in lower estrogen production and a rise
in FSH levels. The combined effects of estrogen
deprivation and increase FSH production induce
an imbalance in bone formation and resorption
via messenger RNS gene expression3
. Genetic
makeup, nutrition, physical activity, body weight,
age, estrogen deficiency, late menarche and sarcopenia, ovarian failure at a young age, cigarette
smoking and alcohol are all risk factors3
.
Clinical Features
The most common clinical manifestations include
vertebral or hip fractures. Scoliosis and kyphosis
are worsened by spinal fractures because of bone
height reduction. In the mandible, the cortex of the
mandibular angle is resorbed and gets thinner, but
in the maxilla, it is negligible in the alveolar crest1,4.
Menopausal women had a higher prevalence and
severity of TMDs than non-menopausal women24.
Diagnosis and management
The measurement of BMD is aided by radiographic
diagnostics. The Gonial index of the inferior mandibular cortex at the angle of jaw is less than 1mm,
indicating osteoporosis. DEXA, FRAX, trabecular
bone score, quantitative CT, spine CT and bone
markers are other tests. Telopeptide, Ntelopeptide and C telopeptide are all bone resorption markers.
Bone ALP osteocalcin is a bone formation marker.
WHO osteoporosis diagnostic criteria- Normal
≥-1SD, osteopenia -1 to -2.5 SD, osteoporosis
≤-2.5 SD4
.
Specifically, lifestyle changes combined with
physical activity that increase skeletal system
mechanical performance. Calcium intake in the
diet (1000-1500mg) and prevention of fall is important. According to Barone, 60% reacted well to
dietary correction with vitamin supplements, 35%
to estrogen therapy and 5% required psychological
assistance. A calcium rich diet followed throughout
adulthood can help to prevent and even reverse
osteoporosis5
. Bisphospohonates are used to treat
glucocorticoid induced osteoporosis, enhance
bone mass in male osteoporosis and prevent
and treat postmenopausal osteoporosis13. Pharmacotherapy includes antiresoprtive drugs like
bisphosphonates denosumab, anabolic agents like
teriparatide. Newer drugs include abaloparatide
and romosozumab4
.
Prosthodontic Considerations
The goal of prosthodontic treatment is to alleviate bone stress. A multidisciplinary approach to
prosthodontic treatment involving a prosthodontist,
gynaecologist, orthopaedic surgeon, psycologist
and nutritionist results in a favourable outcome
and improved patient quality of life20. Bandela et
al stated that reduced biomechanical loading on
bone, decreases tensions within bone, resulting in
resorption within bone and its periosteal surface1
.
Removable dentures
All edentulous people undergoing rehabilitation
should be screened for osteoporosis on regular
basis. While making impression, selective pressure
impression technique, mucostatic or open mouth
techniques are used to lessen mechanical forces.
Periodic evaluation may require more frequent
denture modifications15. In edentulous subjects 6 months after denture placement, osteoporotic
patients had a higher RRR and lower masticatory ability and efficiency. Teeth having a limited
buccolingual width, such as semi anatomic and
non-anatomic are preferable. Optimum use of soft
liners and extended tissue interval are advised.
Bhatia et al described a personalized metal plate
with a looping metal design that minimised burning sensations, allergic reactions and microbial
colonisation16.
Fixed dentures and Implants
FPD will hasten bone loss in periodontally compromised abutments, as a result FPD fabrication
should come after osteoporotic treatment1
. For
patients with osteoporosis, implant therapy is not
contraindicated, however surgical technique and
osseointegration should be properly planned11,14.
The treatment plan for surgical method, healing
period and loading are all influenced by bone density. Implants with a wider width and hydroxyapatite improve bone contact and density18. Without
hormone replacements, postmenopausal women
have a high failure rate. Implant supported overdentures provide greater masticatory forces and
consequently mandibular stress than traditional
dentures. Calcitonin and bisphosphonates are
both indirect inhibitors of bone resorption and
play a role in bone repair and maturation. Cap
modified implant along with PRP could improve
osteoinductive effect, resulting in better bone and
implant interface stabilization25. The simvastatin-Sr-HA coatings would be useful in patients with
osteoporosis who have poor bone quality28. According to findings, implant therapy is a decisive
treatment method for improving the quality of life
in osteoporotic patients by increasing function
and esthetics30.
Burning mouth, atrophic mucosa, impaired taste
sensitivity, osteoporosis, periodontitis and recurrent
infections in denture wear in post-menopausal are all signs of menopause. The situation of missing
teeth replacement is a serious one. Prosthodontic
treatments should be performed in such a way that
bone tension is reduced, resulting in resorption.
Sugar-free chewing gums and sialagogues can
help with xerostomia. It is necessary to maintain
proper dental hygiene. For people with burning
mouths, a metal denture base provides an alternative to acrylic dentures20. To avoid tissue stress,
the denture must be polished smooth. Flexible
dentures or reservoir dentures are two options.
Bone loss and weakening might damage the ridges
that keep dentures in place, resulting in ill-fitting
dentures. To avoid prolonged irritation, denture
adjustments can be made. In osteoporotic women,
oestrogen treatment can help to prevent severe
bone demineralization18. For a proper treatment
plan, an interdisciplinary strategy involving gynaecologist, orthopeardic surgeon, psychologist,
nutritionist and prosthodontist can be used20. Surface treated implants, such as those coated with
hydroxyapaptite, can be utilised to boost bone
density. In osteoporotic patients, proper treatment
planning for dental implants can help improve
osseointegration.
Menopausal oral manifestations are underscored
by current female demographic trends. Tooth
movement, alveolar bone resorption and TMJ
disorders are all major concerns for osteoporotic
individuals. Definitive diagnosis, treatment planning and management are all required.